|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 14-09-16 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 14-09-04 | Roche : rules out mega deals, open to smaller ones - paper | RE |
Executive Committee: InterMune Inc
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Tech/Sci/R&D Officer | 71 | 2002-03-31 | |
Carla Fiankan
LAW | General Counsel | - | 2011-07-31 |
Company details: InterMune Inc
Other Biotechnology & Medical Research
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.54% | -2.84% | -1.90% | +14.52% | 50.35B | |
| -0.40% | +1.03% | +439.20% | +499.20% | 45.2B | |
| -1.42% | +2.30% | +45.46% | +19.36% | 44.71B | |
| -1.22% | -2.31% | +12.40% | +71.48% | 41.24B | |
| +0.53% | -1.36% | +16.04% | +48.23% | 33.08B | |
| -0.21% | +9.14% | - | - | 17.81B | |
| -0.35% | -1.56% | +22.59% | +116.19% | 16.56B | |
| -1.01% | +0.50% | +15.83% | +27.98% | 14.82B | |
| -1.65% | -1.03% | +77.75% | +37.63% | 14B | |
| Average | -0.92% | +0.49% | +78.42% | +104.33% | 30.86B | |
| Weighted average by Cap. | -1.04% | +0.26% | +94.35% | +121.44% |
- Stock Market
- Stocks
- Stock
- Company InterMune Inc
Select your edition
All financial news and data tailored to specific country editions
